With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is heavily dominated by institutional owners

By Yahoo! Finance | Jun 30, 2024 at 08:07 AM EST

Ownership data and analyst forecasts provide valuable insights into a company's potential success. Institutional investors hold a majority stake in Heron Therapeutics, indicating confidence in its future. However, it's crucial to consider other factors beyond ownership when evaluating a company's prospects.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.